Home > Research > Publications & Outputs > The effect on work presenteeism of job retentio...

Electronic data

Links

Text available via DOI:

View graph of relations

The effect on work presenteeism of job retention vocational rehabilitation compared to a written self-help work advice pack for employed people with inflammatory arthritis: protocol for a multi-centre randomised controlled trial (the WORKWELL trial)

Research output: Contribution to Journal/MagazineJournal articlepeer-review

E-pub ahead of print

Standard

The effect on work presenteeism of job retention vocational rehabilitation compared to a written self-help work advice pack for employed people with inflammatory arthritis: protocol for a multi-centre randomised controlled trial (the WORKWELL trial). / Hammond, Alison ; Sutton, Chris; Cotterill, Sarah et al.
In: BMC Musculoskeletal Disorders, Vol. 21, 607, 13.09.2020.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Hammond, A, Sutton, C, Cotterill, S, Woodbridge, S, O'Brien, R, Radford, K, Forshaw, D, Verstappen, S, Jones, C, Marsden, A, Eden, M, Prior, Y, Culley, J, Holland, P, Walker-Bone, K, Hough, Y, O'Neill, T, Ching, A & Parker, J 2020, 'The effect on work presenteeism of job retention vocational rehabilitation compared to a written self-help work advice pack for employed people with inflammatory arthritis: protocol for a multi-centre randomised controlled trial (the WORKWELL trial)', BMC Musculoskeletal Disorders, vol. 21, 607. https://doi.org/10.1186/s12891-020-03619-1

APA

Hammond, A., Sutton, C., Cotterill, S., Woodbridge, S., O'Brien, R., Radford, K., Forshaw, D., Verstappen, S., Jones, C., Marsden, A., Eden, M., Prior, Y., Culley, J., Holland, P., Walker-Bone, K., Hough, Y., O'Neill, T., Ching, A., & Parker, J. (2020). The effect on work presenteeism of job retention vocational rehabilitation compared to a written self-help work advice pack for employed people with inflammatory arthritis: protocol for a multi-centre randomised controlled trial (the WORKWELL trial). BMC Musculoskeletal Disorders, 21, Article 607. Advance online publication. https://doi.org/10.1186/s12891-020-03619-1

Vancouver

Hammond A, Sutton C, Cotterill S, Woodbridge S, O'Brien R, Radford K et al. The effect on work presenteeism of job retention vocational rehabilitation compared to a written self-help work advice pack for employed people with inflammatory arthritis: protocol for a multi-centre randomised controlled trial (the WORKWELL trial). BMC Musculoskeletal Disorders. 2020 Sept 13;21:607. Epub 2020 Sept 13. doi: 10.1186/s12891-020-03619-1

Author

Bibtex

@article{c6ca8f1a55a441688dcdd2ab936074be,
title = "The effect on work presenteeism of job retention vocational rehabilitation compared to a written self-help work advice pack for employed people with inflammatory arthritis: protocol for a multi-centre randomised controlled trial (the WORKWELL trial)",
abstract = "Background: Work problems are common in people with inflammatory arthritis. Up to 50% stop work within 10 years due to their condition and up to 67% report presenteeism (i.e. reduced work productivity), even amongst those with low disease activity. Job retention vocational rehabilitation (JRVR) may help prevent orpostpone job loss and reduce presenteeism through work assessment, work-related rehabilitation and enabling job accommodations. This aims to create a better match between the person{\textquoteright}s abilities and their job demands. Theobjectives of the Workwell trial are to test the overall effectiveness and cost-effectiveness of JRVR (WORKWELL) provided by additionally trained National Health Service (NHS) occupational therapists compared to a control group who receive self-help information both in addition to usual care. Methods: Based on the learning from a feasibility trial (the WORK-IA trial: ISRCTN76777720), the WORKWELL trial is a multi-centre, pragmatic, individually-randomised parallel group superiority trial, including economic evaluation,contextual factors analysis and process evaluation. Two hundred forty employed adults with rheumatoid arthritis, undifferentiated inflammatory arthritis or psoriatic arthritis (in secondary care), aged 18 years or older with work instability will be randomised to one of two groups: a self-help written work advice pack plus usual care (control intervention); or WORKWELL JRVR plus a self-help written work advice pack and usual care. WORKWELL will be delivered by occupational therapists provided with additional JRVR training from the research team. The primary outcome is presenteeism as measured using the Work Limitations Questionnaire-25. A comprehensive range of secondary outcomes of work, health, contextual factors and health resource use are included. Outcomes aremeasured at 6- and 12- months (with 12-months as the primary end-point). A multi-perspective within-trial costeffectiveness analyses will also be conducted.Discussion: This trial will contribute to the evidence base for provision of JRVR to people with inflammatory arthritis. If JRVR is found to be effective in enabling people to keep working, the findings will support decisionmaking about provision of JRVR by rheumatology teams, therapy services and healthcare commissioners, and providing evidence of the effectiveness of JRVR and the economic impact of its implementation.",
keywords = "Arthritis, Vocational rehabilitation, Occupational therapy, Presenteeism, Absenteeism, Randomised controlled trial",
author = "Alison Hammond and Chris Sutton and Sarah Cotterill and Sarah Woodbridge and Rachel O'Brien and Kate Radford and Denise Forshaw and Suzanne Verstappen and Cheryl Jones and Antonia Marsden and Martin Eden and Yeliz Prior and June Culley and Paula Holland and Karen Walker-Bone and Yvonne Hough and Terence O'Neill and Angela Ching and Jennifer Parker",
year = "2020",
month = sep,
day = "13",
doi = "10.1186/s12891-020-03619-1",
language = "English",
volume = "21",
journal = "BMC Musculoskeletal Disorders",
issn = "1471-2474",
publisher = "Springer Nature",

}

RIS

TY - JOUR

T1 - The effect on work presenteeism of job retention vocational rehabilitation compared to a written self-help work advice pack for employed people with inflammatory arthritis: protocol for a multi-centre randomised controlled trial (the WORKWELL trial)

AU - Hammond, Alison

AU - Sutton, Chris

AU - Cotterill, Sarah

AU - Woodbridge, Sarah

AU - O'Brien, Rachel

AU - Radford, Kate

AU - Forshaw, Denise

AU - Verstappen, Suzanne

AU - Jones, Cheryl

AU - Marsden, Antonia

AU - Eden, Martin

AU - Prior, Yeliz

AU - Culley, June

AU - Holland, Paula

AU - Walker-Bone, Karen

AU - Hough, Yvonne

AU - O'Neill, Terence

AU - Ching, Angela

AU - Parker, Jennifer

PY - 2020/9/13

Y1 - 2020/9/13

N2 - Background: Work problems are common in people with inflammatory arthritis. Up to 50% stop work within 10 years due to their condition and up to 67% report presenteeism (i.e. reduced work productivity), even amongst those with low disease activity. Job retention vocational rehabilitation (JRVR) may help prevent orpostpone job loss and reduce presenteeism through work assessment, work-related rehabilitation and enabling job accommodations. This aims to create a better match between the person’s abilities and their job demands. Theobjectives of the Workwell trial are to test the overall effectiveness and cost-effectiveness of JRVR (WORKWELL) provided by additionally trained National Health Service (NHS) occupational therapists compared to a control group who receive self-help information both in addition to usual care. Methods: Based on the learning from a feasibility trial (the WORK-IA trial: ISRCTN76777720), the WORKWELL trial is a multi-centre, pragmatic, individually-randomised parallel group superiority trial, including economic evaluation,contextual factors analysis and process evaluation. Two hundred forty employed adults with rheumatoid arthritis, undifferentiated inflammatory arthritis or psoriatic arthritis (in secondary care), aged 18 years or older with work instability will be randomised to one of two groups: a self-help written work advice pack plus usual care (control intervention); or WORKWELL JRVR plus a self-help written work advice pack and usual care. WORKWELL will be delivered by occupational therapists provided with additional JRVR training from the research team. The primary outcome is presenteeism as measured using the Work Limitations Questionnaire-25. A comprehensive range of secondary outcomes of work, health, contextual factors and health resource use are included. Outcomes aremeasured at 6- and 12- months (with 12-months as the primary end-point). A multi-perspective within-trial costeffectiveness analyses will also be conducted.Discussion: This trial will contribute to the evidence base for provision of JRVR to people with inflammatory arthritis. If JRVR is found to be effective in enabling people to keep working, the findings will support decisionmaking about provision of JRVR by rheumatology teams, therapy services and healthcare commissioners, and providing evidence of the effectiveness of JRVR and the economic impact of its implementation.

AB - Background: Work problems are common in people with inflammatory arthritis. Up to 50% stop work within 10 years due to their condition and up to 67% report presenteeism (i.e. reduced work productivity), even amongst those with low disease activity. Job retention vocational rehabilitation (JRVR) may help prevent orpostpone job loss and reduce presenteeism through work assessment, work-related rehabilitation and enabling job accommodations. This aims to create a better match between the person’s abilities and their job demands. Theobjectives of the Workwell trial are to test the overall effectiveness and cost-effectiveness of JRVR (WORKWELL) provided by additionally trained National Health Service (NHS) occupational therapists compared to a control group who receive self-help information both in addition to usual care. Methods: Based on the learning from a feasibility trial (the WORK-IA trial: ISRCTN76777720), the WORKWELL trial is a multi-centre, pragmatic, individually-randomised parallel group superiority trial, including economic evaluation,contextual factors analysis and process evaluation. Two hundred forty employed adults with rheumatoid arthritis, undifferentiated inflammatory arthritis or psoriatic arthritis (in secondary care), aged 18 years or older with work instability will be randomised to one of two groups: a self-help written work advice pack plus usual care (control intervention); or WORKWELL JRVR plus a self-help written work advice pack and usual care. WORKWELL will be delivered by occupational therapists provided with additional JRVR training from the research team. The primary outcome is presenteeism as measured using the Work Limitations Questionnaire-25. A comprehensive range of secondary outcomes of work, health, contextual factors and health resource use are included. Outcomes aremeasured at 6- and 12- months (with 12-months as the primary end-point). A multi-perspective within-trial costeffectiveness analyses will also be conducted.Discussion: This trial will contribute to the evidence base for provision of JRVR to people with inflammatory arthritis. If JRVR is found to be effective in enabling people to keep working, the findings will support decisionmaking about provision of JRVR by rheumatology teams, therapy services and healthcare commissioners, and providing evidence of the effectiveness of JRVR and the economic impact of its implementation.

KW - Arthritis

KW - Vocational rehabilitation

KW - Occupational therapy

KW - Presenteeism

KW - Absenteeism

KW - Randomised controlled trial

U2 - 10.1186/s12891-020-03619-1

DO - 10.1186/s12891-020-03619-1

M3 - Journal article

VL - 21

JO - BMC Musculoskeletal Disorders

JF - BMC Musculoskeletal Disorders

SN - 1471-2474

M1 - 607

ER -